FindTrial
Sign In

Development and Research on Prediction Model of Gene Mutations in Lung Cancer

Development and Research on Prediction Model of Gene Mutations in Lung Cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500100775
Enrollment
Unknown
Registered
2025-04-15
Start date
2025-05-01
Completion date
Unknown
Last updated
2025-04-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung Cancer

Interventions

Gold Standard:Pathological diagnosis
Index test:Tumor gene detection

Sponsors

Hua County People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients who was diagnosed as lung adenocarcinoma on the first pathologically and was hospitalized in this hospital. All patients signed the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Combined with other malignant tumors; 2. Metastatic lung cancer; 3. Clinicopathological feature data or pathomic data were missing.

Design outcomes

Primary

MeasureTime frame
EGFR mutation;ALK mutation;ROS1 mutation;BRAF V600 mutation;RET mutation;Accuracy;Sensitivity;Specificity;—

Secondary

MeasureTime frame
MET14 mutation;NTRK1/2/3 mutation;PD-1/PD-L1;—

Countries

China

Contacts

Public ContactZesen Han

Hua County People's Hospital

hanzesen908@163.com+86 157 3792 6176

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026